Introduction
============

The intrinsically disordered proteins (IDPs), also called intrinsically unstructured or natively unfolded, are either entirely disordered or contain disordered regions in their native state. These proteins were found to be implicated in numerous cellular processes including signal transduction, transcriptional regulation, and translation,[@R1] protein--DNA[@R2] and protein--protein[@R3] interactions. The disorder was demonstrated to play role in several human diseases,[@R4]^,^[@R5] including AIDS,[@R6] cancer,[@R7] cardiovascular disease,[@R8] neurodegenerative diseases,[@R9]^,^[@R10] genetic diseases[@R11] and amyloidosis.[@R12] Moreover, IDPs have been shown to be abundant in complex organisms.[@R6]^,^[@R13]^,^[@R14] Experimental annotation of disorder lags behind the rapidly growing sizes of the protein databases and thus computational methods are used to close this gap and to investigate the disorder. A curated repository of IDPs, Disprot version 6.01,[@R15] contains 684 chains, whereas the Protein Data Bank (PDB),[@R16] which allows finding unstructured/disordered segments in the solved tertiary structures, includes over 82,000 protein entries. To compare, the current 57 release of RefSeq database[@R17] boasts over 27.8 million of non-redundant protein sequences.

The computational methods that predict disorder from protein chains can be divided into four categories: (1) approaches that utilize the relative propensity of amino acids to form disorder/ordered regions,[@R18]^-^[@R21] (2) methods that are based on classifiers generated with the help of machine learning algorithms,[@R22]^-^[@R37] (3) meta-methods that are based on a consensus of multiple base predictors[@R38]^-^[@R44] and iv) approaches that find disordered residues through an analysis of the predicted 3D structural models.[@R27]^,^[@R45] The disorder prediction is part of the biannual Critical Assessment of techniques for protein Structure Prediction (CASP) experiments since 2002,[@R46] which further signifies interest in this area. Although accuracy of the predictors continues to rise,[@R47]^,^[@R48] the most recent evaluated CASP9 experiment observed lack/small progress in the last couple of years.[@R49] New and more accurate methods are needed, particularly those that are accessible to the end users via convenient web servers. Beside the abovementioned approaches that predict the disorder at the residue level, a few methods that predict propensity of the entire protein chain to be disordered were proposed.[@R50]^-^[@R54] Although these methods were shown to outperform the residues level approaches in some aspects, e.g., in prediction of the disorder content that is defined as fraction of disordered residues in a given protein chain,[@R50]^,^[@R55] they were explored to enhance the residue level predictions only very recently.[@R50] To this end, we present and benchmark a novel disorder predictor, MFDp2, that combines residue-level (using MFDp[@R39]) and sequence-level (using DisCon[@R50]) predictions to improve predictive quality. MFDp2 is implemented as content-rich and user-friendly web server, which allows predictions from individual and multiple protein chains and provides additional helpful information to profile the predicted disorder.

Results and Discussion
======================

Evaluation on the benchmark data set
------------------------------------

We evaluated MFDp2 and compared it against 14 state-of-the-art (18 with sub-versions) disorder predictors on the DP_NEW data set, which has low sequence identity with the training data sets used to build MFDp and DisCon. We considered other predictors that are available to the end user either as web servers or standalone implementations; we use the newest versions of these methods. They include publicly available versions of the top predictors from CASP9, such as PrDos, DISOPRED, Multicom (also called PreDisorder), SPINE-D and MFDp. The considered methods include three fast versions of ESpritz (X, N and D)[@R22] with threshold selected to achieve 5% FPR as this threshold results in higher MCC values (compared with the second suggested threshold that optimizes the Sw measure), SPINE-D,[@R59] two versions of CSpritz (CSpritz Long and CSpritz Short),[@R38] MFDp,[@R39] PONDRFIT,[@R40] MD,[@R42] PreDisorder,[@R41] DISOCLUST,[@R45] PrDos,[@R27] NORSnet,[@R25] UCON,[@R18] two versions of IUPred (IUPred Long and IUPred Short),[@R20] PROFBVAL[@R32] and DISOPRED2.[@R36] PROFBVAL is designed to predict b-factors of residues, which are different than propensity for disorder; however, this method is included here since it is one of inputs of MFDp2 and was often included in related studies.[@R39]^,^[@R42] The results are summarized in [**Table 1**](#T1){ref-type="table"}. Similarly as in other relevant works,[@R38]^,^[@R39]^,^[@R50]^,^[@R55] the unannotated residues in the DP_NEW data set are assumed to be ordered. Results marked as PSI-BLAST were obtained by aligning to disordered segments in the MxD data set, as described in the *Materials and Methods* section (subsection *MFDp2*). They are listed to investigate the impact of the inclusion of the alignment on the results from MFDp2.

###### **Table 1.** Comparison of MFDp2 against disorder predictors where residues without annotations are assumed ordered.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Method             Reference    Year\       Evaluations at residue level   Evaluation at chain level                                                                                                                      
                                  published                                                                                                                                                                                 
  ------------------ ------------ ----------- ------------------------------ --------------------------- ----------- ---------- ---------- ---------- ------------------- ---- ------------------- ---- ------------------- ----
  MFDp2              This paper   2012        **.479** ± 0.043                                           83.2        95.3       75.9       43.5       **0.862** ± 0.019        0.153 ± 0.016            0.708 ± 0.032        

  MFDp2^no\ blast^   This paper   2012        0.475 ± 0.043                  ++                          83.2        95.2       75.4       43.3       0.860 ± 0.019       ++   0.153 ± 0.016       ++   0.707 ± 0.032       ++

  MFDp               [@R39]       2010        0.466 ± 0.039                  ++                          79.3        96.1       80.9       40.0       0.850 ± 0.020       ++   0.174 ± 0.018       ++   0.704 ± 0.032       =

  CSpritz L          [@R38]       2011        **.463** ± 0.026               =                           77.5        **96.5**   **83.5**   38.7       **0.870** ± 0.011   =    0.242 ± 0.016       ++   0.632 ± 0.029       ++

  MD                 [@R42]       2009        0.414 ± 0.034                  ++                          79.9        94.5       72.6       38.1       0.829 ± 0.023       ++   0.235 ± 0.018       ++   0.617 ± 0.035       ++

  ESPRITZ X          [@R22]       2012        0.394 ± 0.028                  ++                          88.7        91.9       53.8       44.7       0.801 ± 0.018       ++   0.139 ± 0.009       −    0.730 ± 0.026       =

  CSpritz S          [@R38]       2011        0.390 ± 0.030                  ++                          77.2        94.5       73.5       35.5       0.823 ± 0.016       ++   0.209 ± 0.011       ++   0.704 ± 0.025       ++

  PrDos\*            [@R27]       2007        0.388 ± 0.028                  ++                          86.8        91.4       55.8       44.0       0.818 ± 0.016       ++   0.137 ± 0.009       −    0.716 ± 0.028       =

  PONDRFIT           [@R40]       2010        0.387 ± 0.032                  ++                          81.5        93.4       66.3       37.9       0.800 ± 0.019       ++   0.162 ± 0.012       ++   0.762 ± 0.025       −

  SPINE-D            [@R59]       2012        0.381 ± 0.037                  ++                          72.9        95.2       78.4       33.0       0.823 ± 0.023       ++   0.204 ± 0.013       ++   0.742 ± 0.023       −

  [IUPRED L]{.ul}    [@R20]       2005        0.380 ± 0.035                  ++                          84.4        92.6       60.4       39.7       0.788 ± 0.022       ++   **0.130** ± 0.015   −    0.762 ± 0.035       −

  PreDisorder\*      [@R41]       2009        0.374 ± 0.029                  ++                          74.1        94.0       74.5       34.8       0.797 ± 0.021       ++   0.234 ± 0.013       ++   0.672 ± 0.032       ++

  [DISOPRED2]{.ul}   [@R36]       2004        0.370 ± 0.043                  ++                          80.5        93.2       65.6       36.4       0.797 ± 0.026       ++   0.153 ± 0.012       =    0.693 ± 0.028       ++

  [IUPRED S]{.ul}    [@R20]       2005        0.368 ± 0.030                  ++                          86.7        91.8       54.5       41.1       0.782 ± 0.019       ++   0.133 ± 0.010       −    **0.784** ± 0.023   −

  ESPRITZ D          [@R22]       2012        0.349 ± 0.044                  ++                          92.0        90.2       40.9       46.7       0.827 ± 0.015       ++   0.186 ± 0.012       ++   0.582 ± 0.037       ++

  [DISOCLUST]{.ul}   [@R45]       2008        0.343 ± 0.056                  ++                          71.3        94.4       75.3       30.8       0.803 ± 0.031       ++   0.190 ± 0.012       ++   0.672 ± 0.029       ++

  ESPRITZ N          [@R22]       2012        0.329 ± 0.026                  ++                          80.5        92.2       60.2       34.4       0.785 ± 0.017       ++   0.168 ± 0.012       ++   0.703 ± 0.021       =

  NORSnet            [@R25]       2007        0.323 ± 0.040                  ++                          87.6        90.7       47.3       39.3       0.761 ± 0.021       ++   0.172 ± 0.018       ++   0.433 ± 0.052       ++

  UCON               [@R18]       2007        0.289 ± 0.036                  ++                          76.6        91.9       60.5       30.6       0.732 ± 0.026       ++   0.179 ± 0.017       ++   0.741 ± 0.043       −

  [PROFBVAL]{.ul}    [@R32]       2006        0.130 ± 0.018                  ++                          65.1        89.0       52.8       20.5       0.631 ± 0.014       ++   0.307 ± 0.011       ++   0.560 ± 0.063       ++

  [PSI-BLAST]{.ul}   N/A          N/A         0.065 ± 0.042                  ++                          **100.0**   85.5       0.5        **92.6**   0.503 ± 0.002       ++   0.193 ± 0.018       ++   0.005 ± 0.022       ++
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of MFDp2 against 18 state-of-the-art disorder predictors on the DP_NEW data set where residues with unknown annotations are assumed ordered. "MFDp2^no\ blast^" denotes results from MFDp2 before the PSI-BLAST enrichment. Results are sorted according to MCC and the best results for each considered quality measure are shown in bold. "Sig" column shows statistical significance of differences measured based on 10 repetitions on randomly chosen 2/3 of the proteins from DP_NEW data set; +/=/− indicate that MFDp2 is significantly better/not significantly different/significantly worse than another method; ++/− − at p-value \< 0.01 and +/− at p-value \< 0.05. The methods that were used to design MFDp, a base predictor of MFDp2, are underlined. \*PrDos and PreDisorder failed to predict the DP00623 protein; the evaluation is based on the remaining 104 chains.

When considering the evaluation at the residue level, MFDp2 offers competitive predictive quality with the highest MCC and second best AUC. The improvements over the existing methods are statistically significant in almost all of the cases. Using the MCC and AUC measures, which were utilized in the most recent CASP9 experiment to evaluate binary predictions and probabilities,[@R49] MFDp2 provides similar predictive performance to CSpritz Long and outperforms all other considered methods, by a moderate to large margin that is in most cases statistically significant. We note that differences between MFDp and MFDp2 (including versions with and without the use of alignment with BLAST) are statistically significant since these methods generate similar results for similar chains, where MFDp2 provides consistent improvements. For the disorder content prediction, which is evaluated at the chain level, a few methods, such as PrDos, ESpritz and IUPred, outperform MFDp2. However, these methods are (significantly) outranked by MFDp2 for the residue level predictions. That means that these methods predict the number of disorder residues more accurately, but they do not predict their position in a sequence as accurately as MFDp2 does. The CSpritz Long method, which provides predictions that are comparable to MFDp2 at the residue level, tends to overpredict the disorder, which is indicated by higher errors in content prediction and high Q~D\ obs~ coupled with a relatively low Q~D\ pred~.

Comparison of the MFDp2 on the DP_NEW data set where the unannotated residues are removed from the evaluation is presented in [**Table 2**](#T2){ref-type="table"}. In this case we could not evaluate the prediction of the disorder content since this chain level measure cannot be calculated when annotations for some residues are missing. MFDp2 achieves the highest MCC and AUC. These improvements are statistically significant, although in some cases the magnitude of the differences is moderate, e.g., MFDp2 improves over MFDp in AUC by 0.013. This small difference is statistically significant since MFDp and MFDp2 generate similar predictions for similar chains, with a moderate improvement in favor of MFDp2. The MFDp2 method also secures third best rank in Q~O\ obs~, fourth in Q~D\ obs~ and Q~O\ pred~, as well as the highest value of Q~D\ pred~ (when we exclude blast alignment which only detects 0.5% of disordered residues). The values of Q~D\ pred~ demonstrate that over 80% of the disorder predictions by MFDp2 are in fact correct. We note that all considered methods have higher values of the corresponding quality meters (except for the Q~D\ obs~, which does not change since the number of disorder residues is the same) when compared with the evaluation where residues with the unknown annotation were assumed to be ordered ([**Table 1**](#T1){ref-type="table"}).

###### **Table 2.** Comparison of MFDp2 against disorder predictors where residues without annotations are disregarded.

  Method             Reference    Year published   MCC ± stdev         Sig   Q~Oobs~     Q~O\ pred~   Q~D\ obs~   Q~D\ pred~   AUC ± stdev         Sig
  ------------------ ------------ ---------------- ------------------- ----- ----------- ------------ ----------- ------------ ------------------- -----
  MFDp2              This paper   2012             **0.729** ± 0.041         95.3        93.9         75.9        80.6         **0.940** ± 0.011    
  MFDp2^no\ blast^   This paper   2012             0.725 ± 0.043       ++    95.3        93.8         75.4        80.5         0.938 ± 0.012       ++
  MFDp               [@R39]       2010             0.704 ± 0.038       ++    92.2        95.0         80.9        72.8         0.925 ± 0.014       ++
  CSpritz L          [@R38]       2011             0.621 ± 0.033       ++    85.9        **95.3**     **83.5**    60.3         0.909 ± 0.014       ++
  [DISOPRED2]{.ul}   [@R36]       2004             0.614 ± 0.037       ++    93.6        91.4         65.6        72.3         0.880 ± 0.019       ++
  [IUPRED L]{.ul}    [@R20]       2005             0.588 ± 0.027       ++    94.3        90.3         60.4        73.1         0.851 ± 0.016       ++
  [DISOCLUST]{.ul}   [@R45]       2008             0.581 ± 0.047       ++    87.4        93.2         75.3        60.6         0.904 ± 0.016       ++
  MD                 [@R42]       2009             0.576 ± 0.036       ++    88.4        92.6         72.6        61.7         0.873 ± 0.022       ++
  PrDos\*            [@R27]       2007             0.576 ± 0.030       ++    95.4        89.5         55.8        75.4         0.883 ± 0.014       ++
  SPINE-D            [@R59]       2012             0.575 ± 0.039       ++    85.4        93.9         78.4        57.9         0.893 ± 0.020       ++
  PONDRFIT           [@R40]       2010             0.558 ± 0.026       ++    90.3        91.2         66.3        63.7         0.850 ± 0.015       ++
  NORSnet            [@R25]       2007             0.540 ± 0.051       ++    96.7        87.7         47.3        78.6         0.834 ± 0.024       ++
  ESPRITZ X          [@R22]       2012             0.540 ± 0.024       ++    94.5        88.8         53.8        71.6         0.845 ± 0.015       ++
  [IUPRED S]{.ul}    [@R20]       2005             0.525 ± 0.026       ++    93.6        88.9         54.5        68.5         0.830 ± 0.016       ++
  CSpritz S          [@R38]       2011             0.512 ± 0.031       ++    83.6        92.5         73.5        53.5         0.857 ± 0.019       ++
  PreDisorder\*      [@R41]       2009             0.503 ± 0.030       ++    82.4        92.7         74.5        51.8         0.850 ± 0.017       ++
  ESPRITZ N          [@R22]       2012             0.492 ± 0.022       ++    89.4        89.7         60.2        59.2         0.844 ± 0.012       ++
  ESPRITZ D          [@R22]       2012             0.426 ± 0.043       ++    94.4        86.2         40.9        65.2         0.866 ± 0.014       ++
  UCON               [@R18]       2007             0.420 ± 0.032       ++    84.4        89.3         60.5        49.9         0.780 ± 0.020       ++
  [PROFBVAL]{.ul}    [@R32]       2006             0.167 ± 0.019       ++    67.2        84.7         52.8        29.2         0.647 ± 0.014       ++
  [PSI-BLAST]{.ul}   N/A          N/A              0.066 ± 0.040       ++    **100.0**   79.7         0.5         **100.0**    0.503 ± 0.002       ++

Comparison of MFDp2 against 18 state-of-the-art disorder predictors on the subset of residues from DP_NEW data set for which annotations are known. We do not use the residues with unknown annotation in the evaluation, which is why the disorder content cannot be computed and evaluated. "MFDp2^no\ blast^" denotes results from MFDp2 before the PSI-BLAST enrichment. Results are sorted according to MCC and the best results for each considered quality measure are shown in bold. "Sig" column shows statistical significance of differences measured based on 10 repetitions on randomly chosen 2/3 of the proteins from DP_NEW data set; +/=/− indicate that MFDp2 is significantly better/not significantly different/significantly worse than another method; ++/− − at *p*-value \< 0.01, +/− at *p*-value \< 0.05. MAE and PCC values for this evaluation cannot be calculated. The methods that were used to design MFDp, a base predictor of MFDp2, are underlined. \*PrDos and PreDisorder failed to predict the DP00623 protein; the evaluation is based on the remaining 104 chains.

We also analyze improvements gained by enrichment of the predictions with the use of the alignment against the disorder segments from the training data set. The results in the last row in [**Tables 1**](#T1){ref-type="table"}**and**[**2**](#T2){ref-type="table"} reveal that BLAST, which is used as described in the *Materials and Methods* section, predicts a small number of disorder residues (low Q~D\ obs~) but with high quality (high Q~D\ pred~). The low Q~D\ obs~ can be explained by the fact that the similarity between the test chains and the chains in the alignment (training) data set is relatively low. The inclusion of BLAST-based alignment into MFDp2 (see the first two rows in [**Tables 1**](#T1){ref-type="table"}**and**[**2**](#T2){ref-type="table"}) results in small but statistically significant (i.e., consistent) improvements. Moreover, differences in the Q~D\ obs~ measure reveal that almost all disordered residues that were predicted based on the alignment were not predicted by MFDp2 without the alignment, i.e., the Q~D\ obs~ is improved by about 0.5 between MFDp2 and MFDp2^no\ blast^, which is consistent with the Q~D\ obs~ of BLAST.

Importantly, for both evaluations (when removing unannotated resides or assuming that they are ordered) MFDp2 is shown to improve over its predecessor MFDp based on the key performance indices including MCC, AUC and MAE. This indicates that optimizing MFDp predictions using the chain-level disorder content predicted by DisCon and adding annotations from aligned disorder regions is beneficial.

Overview and presentation of the web server
-------------------------------------------

The web server is designed to be simple to use. The submission page includes a text field where up to 100 protein sequences in FASTA format can be pasted and another text field for a user email. The email is optional and is used to send notification once the predictions are completed. Server also provides an option to submit proteins in FASTA-formatted file. The results are also shown and linked directly in a browser window. Once the protein sequences are provided, the user clicks "Run MFDp2" button, and this job is added to server's queue. We process the requests in the order in which they were received. The user receives updates concerning the position of their job in the queue and confirmation once the job is being processed. Once computations are finished, the user receives direct links to the location of the results; the same links are sent via email, if it was provided. The results are stored online for at least 3 mo following the submission. The MFDp2's execution time is approximately 5--15 min for an average size protein chain. The time is mostly determined by the time to run PSI-BLAST and is comparable to other predictors such as CSpritz, MD and DISOPRED2.

The results are displayed at two levels. The first level is an overview of all submitted proteins; see [**Figure 1A**](#F1){ref-type="fig"}. It lists the query proteins and for each provides information about the predicted disorder content, number of disorder segments and color-coded sequence where red/green residues correspond to predicted disordered/ordered residues. Clicking on a protein name or sequence redirects the user to another (second level) page with detailed information about the predicted disorder for this protein; see [**Figure 1B**](#F1){ref-type="fig"}. This page includes comprehensive information that allows profiling the predicted disorder. The profile includes conveniently visualized information concerning predicted secondary structure, relative solvent accessibility, profiles of disorder predictions that are used by MFDp2 and PSI-BLAST-based sequence alignment. The profile is color-coded to ease the interpretation where a spectrum of colors between red and green corresponds to the bias toward disordered and ordered conformations, respectively. For instance, using the example from [**Figure 1B**](#F1){ref-type="fig"}, we observe that the disordered segment predicted by MFDp2 at the C-terminus (top of the panel B) is predicted by PSIPRED[@R57] to include two helical segments, predicted by MFDp to be disordered, is solvent inaccessible as predicted by Real-SPINE3,[@R58] and part of this disordered segments was enriched using alignment with PSI-BLAST. This page also contains a list of predicted disorder segments along with their sequence, length, position in the chain and size relative to the size of the full chain. The overview page (see [**Fig. 1A**](#F1){ref-type="fig"}) offers an option to download predictions as parsable text files. Along with the MFDp2 predictions, the user may choose to download additional information including predictions from MFDp and DisCon, secondary structure predicted by PSIPRED and relative solvent accessibility predicted by Real-SPINE3. The text files can be downloaded in two formats: as comma-separable CSV and/or FASTA.

![**Figure 1.** Screenshots of the pages that present results generated by the MFDp2 web server. (**A**) shows the overview page where basic information about predicted disorder for all submitted proteins is displayed. (**B**) shows a detailed results page where more detailed information about predicted disorder for a selected protein is presented.](kidp-01-01-10924428-g001){#F1}

The help and tutorial page can be accessed at the top of the main web server page. This page provides tutorial on how to use the web server and detailed explanations on how to read the results. Individual subsections of this page are hyperlinked within this page and from the pages that the user encounters when interacting with the server to ease reading and finding of this information. The explanations are supplemented with annotated screenshots. The "?" buttons are placed thorough all web server pages next to the sections which may require explanation. These buttons implement direct hyperlinks to the help and hints related to the selected section/task.

Materials and Methods
=====================

MFDp2 uses the disorder content predicted by DisCon[@R50] to correct the per-residue predictions generated with MFDp.[@R39] These corrected predictions are processed, by transformation of probabilities and sliding window-based averaging, to further improve predictive performance. Finally, predictions are enriched by PSI-BLAST[@R56] alignments to (training) chains with annotated disordered segments; we transfer annotated disordered residues from the aligned positions.

MFDp and DisCon
---------------

MFDp is an ensemble of three Support Vector Machines specialized for the prediction of short (\< 30 residues; SVM~SHORT~), long (≥ 30 residues; SVM~LONG~) and generic disordered regions (all disordered residues; SVM~ALL~). This ensemble combines results generated by three disorder predictors together with the information extracted from the input sequence, sequence profiles (PSI-BLAST[@R56]) and predicted secondary structure (PSIPRED[@R57]), solvent accessibility (Real-SPINE3[@R58]), backbone dihedral torsion angles (Real-SPINE3), residue flexibility and B-factors (PROFbval[@R32]). MFDp utilizes a custom-designed set of features that are based on raw predictions and aggregated (using sequence window) raw values. The real-valued prediction is computed as a maximum among the probabilities generated by SVM~ALL~, SVM~SHORT~ and SVM~LONG~ (we combine all predicted disordered residues), and the resulting value is binarized using the threshold = 0.37. In the final step, the predictions are filtered to remove short (2 or fewer residues) disordered segments. A method based on MFDp was ranked second best in the binary disorder prediction in the most recent CASP9.[@R49]

DisCon uses a small set of 29 custom-designed numerical descriptors that hybridize information concerning the input sequence, evolutionary profiles (PSI-BLAST), and predicted secondary structure (PSIPRED), solvent accessibility (Real-SPINE3), flexibility (PROFbval) and annotation of globular domains (IUpred[@R20]). The features aggregate the abovementioned predicted structural and functional properties over the entire input protein chain and their values are fed into a ridge regression model that is used to generate the disorder content. The output is a real value in the \[0, 1\] range that corresponds to the predicted fraction of disordered residues in the input protein. DisCon was shown to predict the per-protein disorder content more accurately than MFDp and several other disorder predictors.[@R50]

MFDp2
-----

The overall architecture of MFDp2, which shows how MFDp and DisCon are combined together and enriched, is presented in [Figure 2](#F2){ref-type="fig"}. The predictions generated by MFDp2 are based on the per-residue disorder probabilities outputted by MFDp, which were converted into binary disorder predictions using the default threshold of 0.37. We analyzed this conversion using a benchmark data set, called MxD, which was used to evaluate MFDp.[@R39] We investigated the ability of MFDp to distinguish between proteins with high and low amount of disorder, i.e., above and below a cut-off value that is varied between 0 and 1 with step of 0.05, and compared it to the results of DisCon. The cut-offs at 0 and 1 correspond to detection of the fully ordered and fully disordered chain, respectively; the intermediate cut-offs correspond to a binary prediction that finds partially structured vs. partially unstructured chains, see [Figure 3](#F3){ref-type="fig"}. Our analysis shows that DisCon outperforms MFDp in the above binary protein level prediction when the MFDp predicted content is between 0.35 and 0.85. Consequently, we change the threshold used by MFDp to match the content predicted by DisCon when the content predicted by MFDp is between 0.35 and 0.85, and otherwise we use the default 0.37 threshold. Next, the resulting thresholds are shifted to 0.5, which is a value recommended in the CASP experiments. Specifically, we use min-max normalization to shift (0, threshold) range to (0, 0.5) and to transform (threshold, 1) range to (0.5, 1). While shifting probabilities, we also adjust their values taking into account the predicted disorder content, i.e., we increase probabilities for predicted disorder residues for proteins with high-predicted disorder content and decrease probabilities for residues predicted as ordered for proteins with low disorder content. Finally, we average the resulting probabilities using a sliding window with 21 residues. This step smoothes out the probability profiles; we used it to improve MFDp's predictions for the CASP9. We selected the window size that provides the highest MCC when predicting disorder on the MxD data set. Afterwards, we remove (by adjusting probabilities) predicted ordered and disordered segments that are shorter than 4 residues, similarly as in the original MFDp.[@R39] Finally, the resulting predictions are enriched with disorder segments found by PSI-BLAST[@R56] against the training data set. This step was introduced to improve prediction accuracy by finding protein fragments that are similar to the disordered segments in the training data set. We hypothesize that segments in the input protein chain that are very similar or identical to the disordered segments in other proteins are likely to be disordered, and that the probability associated with their predicted disorder should be higher if they are aligned to a larger number of natively disordered segments. We use BLAST-based alignment to find similar segments. We also made sure to properly validate this approach, so that we do not overtif the results by allowing high similarity between training chains (that are aligned to) and test chains (that are inputs for the alignment); when testing MFDp2, we used the MxD data set as the training data set and a test data set that shares low sequence identity with the MxD set (see *Dataset* section). We perform alignment with default parameters against chains in the training data set and consider all alignments below 0.001 *e*-value threshold; this cut-off was found to be optimal based on 5-fold cross-validation on the MxD data set. For each position in a given query sequence we count *n*, which is the number of aligned disordered residues across all aligned sequences that satisfy the threshold. If *n* = 0 then we do not change the current output from MFDp2. For every position where *n* ≥ 1 and which belongs to a segment of at least three consecutive residues with *n* ≥ 1, we compute the final probability, which is outputted by MFDp2, as:

![**Figure 2.** Architecture of MFDp2.](kidp-01-01-10924428-g002){#F2}

![**Figure 3.** Selection of disorder content thresholds for MFDp2 using sequence-based binary predictions. The MCC values (y-axis) for the sequence-based binary prediction where the labels are defined as 1/0 when the amount of the native disorder is below/above a cut-off value shown on the x-axis, respectively. The binary predictions are computed by thresholding the predicted disorder content generated by DisCon, MFDp and the four disorder predictors that are used as input to MFDp. The results were generated using the MxD data set and details concerning this analysis could be found in reference [@R50].](kidp-01-01-10924428-g003){#F3}

where *pr(i)* is the probability of disorder for *i*^th^ residue in a query chain generated by MFDp2 before the alignment is added, "1.5" is a constant that assures that the final probability will be ≥ 0.5 when *n* ≥ 1 \[given *n* = 1, the result will be (*pr*(*i*) + 1)/2 = *pr*(*i*)/2 + 0.5, which is ≥ 0.5 for any *pr*(*i*); given *n* = 2, the result will be *pr*(*i*)/2 + 0.625\], and minimum is used to assure that the final probability does not exceed 1.

Dataset
-------

We follow definition of disorder as in,[@R39] i.e., we use two types of annotations to label disordered residues: PDB REMARK 465 and curated annotations extracted from Disprot database.[@R15] We validate our web server and compare it with 14 state-of-the-art competing methods on proteins added to Disprot after release 4.6 (which was used to build the MxD data set that was utilized to build MFDp and DisCon methods) and to PDB[@R16] after August 1, 2011. Among these proteins, we removed those that share over 25% sequence identity to any chain in the MxD data set and the training data sets used by one of the most recent disorder predictors CSpritz.[@R38] The remaining 105 proteins are unlikely to be used to build the other considered methods (they were deposited/annotated after these methods were developed) and share low similarity to our and CSpritz training proteins. These proteins were annotated using the Disprot and PDB disorder annotations, depending on their source. The PDB-based annotations follow the protocol from CASP.[@R49] The Disprot annotations were enriched with PDB REMARK 465 annotations following procedures described in.[@R55] Specifically, the chains taken from Disprot were searched using PSI-BLAST[@R56] against PDB (3 iterations, e-value \< 0.001) and we selected the best hit with sequence identity ≥ 98% (over aligned region) and alignment coverage ≥ 90%. Using the alignment, the PDB-based disorder/order annotations were mapped for the aligned region, and we kept the original disorder annotations from Disprot. The native disordered segments smaller than 4 residues were ignored during evaluation of the final version of the database; this is consistent with CASP. We note that 22.4% of residues lack annotations. The reason is that residues in some proteins from Disprot lack annotations and the annotation for these residues were not transferred from PDB. Thus, we perform evaluations twice: (1) when assuming that these unannotated residues are ordered, which is consistent with several related studies,[@R38]^,^[@R39]^,^[@R50]^,^[@R55] and (2) when disregarding these unannotated residues. Our benchmark data set with the 105 annotated proteins, called DP_NEW, is available on the web server page at biomine.ece.ualberta.ca/MFDp2/.

Evaluation and statistical analysis
-----------------------------------

The assessment of the predictions uses the same criteria as in the CASP experiments.[@R47]^-^[@R49] Additionally, we also evaluate predicted disorder content. The predictions are at three levels: (1) the binary value that defines whether a given residue is or is not disordered, (2) the real value that quantifies probability of disorder and (3) a disorder content for a whole protein sequence. The binary predictions were assessed using five measures:

MCC = (TP\*TN − FP\*FN)/sqrt\[(TP + FP)(TP + FN)(TN + FP)(TN + FN)\]

Q~D~ observed (sensitivity) = TP/(TP + FN)

Q~D~ predicted = TP/(TP + FP)

Q~O~ observed (specificity) = TN/(TN + FP)

Q~O~ predicted = TN/(TN + FN)

where TP is the number of true positives (correctly predicted disordered residues), FP denotes false positives (ordered residues that were predicted as disordered),TN denotes true negatives (correctly predicted ordered residues) and FN stands for false negatives (disordered residues that were predicted ordered). The MCC values range between −1 and 1, and it is equal zero when all residues are predicted to be ordered or disordered. Higher values of these measures correspond to higher quality predictions. We do not include Q~2~ accuracy that was deemed unsuitable for disorder assessment in the last CASP9 evaluation.[@R49] Moreover, balanced accuracy (average of sensitivity and specificity) can be easily inferred from Q~D~ observed and Q~O~ observed that we report, and S~w~ was shown to be linearly related to balanced accuracy; thus it was not reported in CASP9 and we opted not to report it either.49

The Receiver Operating Characteristic (ROC) curve was used to examine the predicted probabilities. For each value of probability *p* generated by a given method, all the residues with probability equal to or greater than *p* are set as disordered, and all other residues are set as ordered. Next, the TP-rate and the FP-rate are calculated, and we use the area under the curve (AUC) to quantify the predictive quality.

The quality of the disorder content prediction was assessed using two popular measures:

Pearson Correlation Coefficient (PCC) = $${\sum\limits_{i = 1}^{n}{(x_{i} - avg_{X})(y_{i} - avg_{Y})}}/{(n - 1)s_{x}s_{y}}$$

Mean Absolute Error (MAE) = $${\sum\limits_{i = 1}^{n}\left| {y_{i} - x_{i}} \right|}/n$$

where *n* is the sample size, *y~i~*∈*Y* is the native and *x~i~*∈*X* is the predicted disorder content for the *i*^th^ protein chain, avg*~X~* and avg*~Y~* are the sample means of *X* and *Y*, *s~x~* and *s~y~* are the sample standard deviations of *X* and *Y*. Following CASP evaluations, we are reporting MCC, AUC, MAE and PCC with three digits after the decimal point and the remaining scores with one digit after the decimal point.

Statistical significance of the differences between MFDp2 and the other considered predictors was measured based on values of the abovementioned quality measures over 10 repetitions on randomly chosen 2/3 of the proteins from the DP_NEW data set. The results were compared between a given pair of predictors using the homeostatic Student's t-test (for equal variances) or Student's t-test (otherwise) if distributions were normal, or with the Mann-Whitney test, if not. Distribution type was verified using the Anderson-Darling test, and equality of variances was tested with Bartlett\'s test.

Conclusions
===========

We introduce a novel web server for disorder prediction, called MFDp2, which is based on MFDp disorder predictor and DisCon disorder content predictor. MFDp2 provides competitive per-residue and disorder content predictions when compared with its predecessor MFDp and 18 other state-of-the-art disorder predictors, including publicly available versions of the top predictors from CASP9. The server is free and open to all users, enables processing of large data sets and presents detailed results with a convenient color-coded disorder profile. The profile visualizes factors that influence the final prediction, including residue conservation, predicted secondary structure, solvent accessibility, flexibility, disorder predictions that are used by MFDp2 and sequence alignment. We provide an easy download of parsable text-based results along with user-selected additional information concerning predicted secondary structure and solvent accessibility. The server also includes tutorial and help pages to assist new users.

AUC

:   area under the receiver operating characteristic curve

CASP

:   critical assessment of techniques for protein structure prediction

IDP

:   intrinsically disordered protein

MAE

:   mean absolute error

MCC

:   Mathews correlation coefficient

PCC

:   Pearson correlation coefficient

PDB

:   Protein Data Bank

SVM

:   support vector machine
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